Follow the Biosino Bio-Technology and Science Incorporation - H Shares share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Market capitalisation: €208m. The latest transaction was disclosed on 15 July 2026 (Purchase). Among the most active insiders: Kang Rui. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€1m
10 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,369 of 29,064 companies
16.9
score / 100
Value
11
Quality
23
FCF yld-15%
Earn yld-24%
EV/EBITDA·
ROE-44%
Gross mgn38%
Net mgn-28%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,000 shares@ HK$3.485.8% of flowShareXHKGHKEX:DA20260601E00019
10 of 10 declarations
About Biosino Bio-Technology and Science Incorporation - H Shares
Biosino Bio-Technology and Science Incorporation - H Shares is a company specializing in biotechnology and life sciences. It focuses on the development and commercialization of innovative products and services in the healthcare sector.